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Background Empyema is a well-known sequelae of
pneumonia, which is increasingly being reported in children
despite strict management. The appropriate management
remains controversial. The aim of this study was to
evaluate different management options of postpneumonic
empyema in children.
Materials and methods A total of 330 patients were
reviewed between 2002 and 2012; their ages ranged
from 1.25 to 15 years, with a median age of 4.3 years.
The various management procedures included
thoracentesis (n = 11), chest tube drainage (n = 229),
chest tube drainage with intrapleural fibrinolytic therapy
(n = 117), video-assisted thoracoscopic surgery (VATS)
(n = 35), and thoracotomy because of a trapped lung
noted on admissions and failed procedures (n = 94).
Results Variable success rates were noted as follows:
tube thoracotomy (48.24%), fibrinolytic treatment (68.37%),
and VATS (85.71%). Postoperative complications (11.14%)
included wound infection (n = 10), atelectasis (n = 18),
delayed expansion (n = 7), and need for reoperation
(n = 2). Four patients died (1.21%), two of them following
thoracotomy, one patient after fibrinolysis, and one patient
following VATS. Patients treated with thoracotomy
recovered completely.
Conclusion New therapeutic modalities had variable
success rates in children with postpneumonic empyema.
Thoracotomy is still needed as a last resort for cases
unresponsive to chemical fibrinolysis and following failed
thoracoscopy. Ann Pediatr Surg 9:131–135 c 2013 Annals
of Pediatric Surgery.
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Introduction
The incidence of empyema is increasing worldwide, causing
significant childhood morbidity, with an estimated 0.6% of
childhood pneumonia progressing to empyema [1–5]. The
aim of treatment in empyema is to sterilize the pleural
cavity, reduce fever, and ensure full expansion of the lung
and its return to normal function. Many treatment options
are available including antibiotics alone or in combination
with thoracentesis, chest-drain insertion, chest drain and
fibrinolytics, and decortication through thoracotomy or
video-assisted thoracoscopic surgery (VATS).
Intrapleural fibrinolytic agents (urokinase and strepto-
kinase) have been shown to be safe in several studies and
have been found to play an important role in the
treatment of empyema [6,7]. Some centers use fibrino-
lytics and in the event of failure, patients will undergo
either open decortication or VATS [8]. The treatment
is not yet standardized and currently patient care is
dependent on local practice and physician preference.
Success rates with these treatment regimens have been
highly variable, most likely related to the stage of
empyema at presentation [4,5].
The aim of this study was to assess different treatment
options in the management of postpneumonic pediatric
empyemas.
Materials and methods
Between 2002 and 2012, 330 children (182 boys and 148
girls) were hospitalized with postpneumonic empyema in
our clinic. Their ages ranged from 1.25 to 15 years, with a
median age of 4.3 years. Patients were included if they
were younger than 15 years of age and had radiographic
evidence of empyema (pleural fluid on chest radiograph
and ultrasound). Cases other than postpneumonic
empyema were excluded.
Indications for drainage were a persistent fever of 381C
(1001F) or greater after more than 24 h of parenteral
antibiotic treatment or respiratory distress (tachypnea
and/or oxygen requirement) caused by the pleural collection.
The laboratory investigations included blood culture,
hemogram, differential counts, coagulation profile,
C-reactive protein, electrolytes, albumin and lactate
dehydrogenase, glucose, and pH values in pleural tap.
For successful drainage, imaging facilities of the chest
were obtained to determine the proper chest tube
insertion when pleural effusions were difficult to access
and to detect loculations.
The diagnosis of empyema required one or more of the
following characteristics: (a) grossly purulent pleural fluid
documented by thoracentesis, (b) pleural fluid glucose
level less than 50 mg/dl, (c) pleural fluid level pH below
7.00, (d) positive Gram stain, and (e) pleural fluid lactate
dehydrogenase level above 1000 IU/l.
Initially, all patients were managed with wide-spectrum
antibiotics (ampicillin/sulbactam) and were later tailored
toward positive culture results. In acute empyemas and
parapneumonic effusions, the first step in treatment was
pleural aspiration plus lavage; 11 patients (4.94%) were
treated in this manner. The second step was chest tube
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insertion. Patients whose conditions did not improve clini-
cally and radiologically with thoracotomy were considered for
intrapleural fibrinolytic therapy. In patients with inadequate
drainage, thoracic ultrasonograms and/or computed tomo-
graphy (CT) were obtained for the presence and sites of the
loculations. In these patients, a second chest tube was
inserted to facilitate drainage. Patients were classified into
five initial treatment groups: group A: thoracentesis alone
(n = 11); group B: chest tube drainage alone (n = 229);
group C: fibrinolytic therapy after inadequate chest tube
drainage (n = 117); group D: VATS following failed fibrino-
lytic therapy (n = 35); and group E: thoracotomy after lung
entrapment and failed procedures (n = 94).
Multiloculation was detected radiologically. The main multi-
loculation criteria were as follows: viscous pleural fluid with
septations consisting of fibrin clusters detected by ultra-
sonography, no improvement in the chest radiograph view
after chest tube insertion, viscous and less empyema fluid
drainage than expected relative to films, and continued fluid
aspiration with thoracentesis after thoracotomy. Strepto-
kinase, 250 000 U in 100 ml of 0.9% saline solution, instead
of urokinase, was instilled daily into the chest tube and the
tube was clamped for 4 h. Mobilization of the patient was
encouraged. The drain was then unclamped and placed on a
negative suction pressure of 10–20 cm of H2O until the next
instillation. This treatment was continued daily for 3–7 days
until resolution was achieved by chest radiograms or
computed chest tomography. Patients were also observed
for signs of anaphylaxis, respiratory decompensation, chest
pain, and bleeding.
In patients without clinical and radiological improvement,
or no increase in pleural fluid drainage, or in whom an
allergic reaction developed, fibrinolytic treatment was
discontinued. Failure was defined as persistent fever of
more than 381C for 4 days after intervention, associated
with persistence of fluid on pleural ultrasound scan.
After instillation, those who failed fibrinolytic treatment
received VATS or decortication. VATS was performed
through three ports and under general anesthesia. The
free fluid was evacuated and loculations were drained, the
fibrinous adhesions were separated, and the pleural debris
removed from the pleural lining using endoscopic
grasping forceps or by extensive irrigation and suction.
After the procedure, one or two chest drains were placed
in port holes on negative suction pressure of 10–20 cm of
H2O to facilitate further drainage.
In all patients, the chest drains were removed when there
was minimal drainage (40–60 ml/24 h) and the patients were
discharged home if they remained afebrile for 48 h after
drain removal. Patients whose conditions did not improve
clinically with thoracotomy, fibrinolysis, or VATS were
considered for open decortication. All decortications were
performed through muscle-sparing thoracotomy. Therefore,
the fibrinous peel on the surface of the visceral and parietal
pleura was removed carefully with success.
Statistical analysis
Median values were calculated for discrete variables.
All categorical variables were presented as number of
patients and percentages. The median of five groups was
analyzed using the Kruskal–Wallis test, followed by the
post-hoc Mann–Whitney corrected Bonferroni test. Two-
sided P values were considered statistically significant at
a P value of 0.05 or less. Statistical analyses were carried
out using the statistical packages for SPSS 15.0 for
Windows (SPSS Inc., Chicago, Illinois, USA).
Results
Pleural fluid culture results are shown in Fig. 1. Micro-
biologic studies of pleural aspiration fluid showed that
Staphylococcus aureus was the most common pathogen in 48
(14.6%) patients. Polymicrobial results were 1.78%. The
blood culture was positive in 12 (3.6%) cases in addition
to bacterial growth in pleural fluid culture. No agent was
isolated from the cultures of 61.0% of patients.
Eleven patients (4.94%) were treated with repeated
thoracentesis and appropriate intravenous antibiotics
(group A). Closed-tube thoracotomy was performed in
229 patients (group B), and 109 (47.59%) of them were
treated successfully in this way. Bronchopleural fistula
was seen in three patients. Two patients died because of
accompanying pneumonia and one underwent thoracot-
omy. In the remaining 117 patients with chest drain
(group C), streptokinase was used as fibrinolytic therapy.
Death followed an allergic reaction and pleural hemor-
rhage in one patient. One patient developed broncho-
pleural fistula. Fibrinolysis was successful in 80 (68.37%)
patients. VATS was performed in the remaining 35 cases
(group D). VATS failed in five (14.28%) cases and one
patient died in this group. Group E included 94 patients
(90 cases of lung entrapment on the admission CT and
four patients of failed procedures). This group underwent
thoracotomy for decortication.
All patients of group C showed an increase in chest tube
drainage within 24 h following instillation of a fibrinolytic
agent, with volume of drainage considerably greater than
that instilled. Most of the improved drainage was within
48 h. The coagulation parameters of all our patients
remained within normal limits before and after fibrinolytic
therapy. Overall, a response rate was obtained in 80 patients
with fibrinolytics. Treatment was ineffective in 35 of 117
patients who underwent streptokinase instillation; they were
Fig. 1
Microbiological results of patients.
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then considered for further surgery and underwent thor-
acotomy or VATS.
Diagnostic thoracentesis was negative or minimal in 90
patients. After initial thoracentesis and thoracotomy,
these patients underwent thoracotomy for decortication
because of trapped lung on chest CT. In addition to
decortication, pulmonary resections were performed in
five patients. We performed lobectomy in two, wedge
resection in one, and segmentectomy in two patients. All
patients recovered completely in the thoracotomy group
(Table 1).
Postoperative complications (11.14%) included incisional
infection in 10 patients, atelectasis in 18 patients,
delayed expansion in seven patients, and reoperation
after hemorrhage in two patients. In cases with wound
infection, complete resolution was achieved with anti-
biotics tailored to culture results and repeated dressings.
Atelectasis was treated with respiratory exercise and
nasotracheal aspiration; no bronchoscopy was needed.
Indication for reoperation in a 7-year-old child was the
oozing of 300 ml/day through the chest tube. Intercostal
artery ligation was performed in this case.
Patients were regularly seen at the polyclinic at 10, 30,
and 90 days after discharge. Four patients died because of
sepsis, heart failure, pneumonia, or pleural hemorrhage
(1.21%). These four patients presented with congestive
heart failure and pneumonia at the time of admittance.
In one patient with fibrinopurulent phase empyema,
intrapleural streptokinase treatment was discontinued
because of hemorrhagic drainage. In the thoracotomy
group, all patients recovered completely and no deaths
occurred.
The baseline characteristics and results are summarized
in Table 1. All data were analyzed according to the
intention-to-treat principle. The median of five groups
was analyzed using the Kruskal–Wallis test, followed by
the post-hoc Mann–Whitney corrected Bonferroni test.
According to the results of the test, symptom history
(days), postintervention hospital stay (days), and success
rate were found to be significantly different (Pr 0.05).
Patients successfully treated within group A had a shorter
duration of median hospital stay of 9 days (range 5–12).
Patients with VATS, group D, had a shorter postinterven-
tion hospital stay of 10.0 days (range 5–11) compared
with children who received fibrinolytic therapy, group C
(11.0 days; range 7–17). The median hospital stay after
open surgery, group E, was 10.5 days (range 6–13)
(Fig. 2).
Discussion
Pleural effusion that may develop during the course of
nonspecific bacterial pneumonia can progress to empy-
ema for several reasons including malnutrition, immuno-
deficiency, irregular antibiotic treatment, delay in diag-
nosis of pneumonia, contamination during thoracentesis,
the tendency for antibiotic treatment in the acute phase
in pediatric clinics, and disappearance of the signs and
symptoms of pneumonia [1].
Determination of the empyema has been reported to be
crucial in choosing an appropriate therapeutic option [9].
The duration of hospital treatment of patients with
empyema is longer in those with parapneumonic effusion.
If untreated, empyema progresses to a fibrinopurulent
nature in a short time, leading to more fibrin accumula-
tion in the pleural area. Aspiration may fail to treat
empyema unless the pleural fluid is free flowing.
Obtaining pleural effusion by thoracentesis may some-
times be difficult even using a large needle. Chest tube
Table 1 Baseline characteristics and results of the groups








N 11 229 117 35 94
Age (years) (range) 4.3 (1.25–15)
Sex (male/female) 6/5 126/103 59/58 18/17 49/45
Symptom history
(days)





9.0 10.0 11.0 10.0 10.5 0.039 A–B; A–C; A–D; A–E; <0.05
Success (%) 4.94 47.59 68.37 85.71 100.00 < 0.001 A–B; A–C; A–D; A–E; B–C;
B–D; B–E; C–D; C–E; D–E;
<0.001
Morbidity (n) 1 9 11 9 7
Mortality (n) – 2 1 1 –
aKruskal–Wallis test was used to analyze the median of five groups (A, B, C, D, and E).
bPost-hoc Mann–Whitney corrected Bonferroni test was used to analyze paired groups that were found to be significant by the Kruskal–Wallis test.
Fig. 2
Length of hospital stay of various groups.
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drainage becomes the mainstay treatment when the
effusion continues to increase.
The total hospital stay reached 26 days for some patients
who finally underwent decortication. Hospital duration of
our patients was longer than those reported in the
literature. This may be related to the need for longer
preparation and observation as well as the relatively high
mean number of multiloculated chronic cases [10].
This retrospective study aimed to show whether there is
significant clinical difference in the duration of hospital
stay after intervention among chest tube drainage alone,
intrapleural fibrinolysis over chest tubes, and VATS for
the treatment of empyema in children. Although there
have been many case series comparing surgical interven-
tions with fibrinolytics, the aim of instillation of
fibrinolytics into the pleural cavity is to lyse the fibrinous
strands and clear lymphatic pores, thus improving
drainage [11–13]. Because of the reported low success
rate of tube thoracotomy for loculated empyema, alter-
native approaches have been developed. Several reports
have documented successful drainage of multiloculated
empyema using streptokinase and urokinase admin-
istrated through a single chest tube [14–16]. In multi-
loculated cases, fibrinolytic instillation had a success rate
of 68.37%, whereas this rate was 100% with open
thoracotomy for decortication.
The use of VATS for the primary treatment of empyema in
children has been gaining popularity over the past decade.
Proponents of VATS suggest that it has a potential advantage
over open surgery of limiting the morbidity to skin, muscles,
nerves, and supporting structures that occur after a large
surgical incision entailing pain, infection, limitation of
movement, and cosmetic scarring [17–20]. Furthermore,
VATS may reduce cytokine responses compared with
conventional surgery [21]. The major limitation of VATS is
the absence of skilled operators; poor results have been
reported in some centers and surgical expertise to perform
pediatric VATS is limited to some centers [22,23]. It was
reported that a group of patients in the fibrinopurulent
phase were treated with VATS and compared with patients
treated by formal thoracotomy [24]; patients with VATS in
that series had the same success rate as open thoracotomy
but offered substantial advantages over thoracotomy in terms
of resolution of the disease, hospital stay, and cosmesis [24].
We started treating with VATS and have achieved
positive outcomes in 85.71% of 35 cases. We specifically
found that VATS is an encouraging treatment option in
cases of the fibrinopurulent phase. Our study was not
designed as an equivalence study as we based our
hypothesis on previously reported results and expected
patients were randomly selected for VATS treatment to
shorten their hospital stay.
In evaluating the most effective management approach,
we identified our primary outcome measure as the length
of hospital stay following intervention, rather than as the
total hospital stay. The treatment groups in the study
were well matched for baseline characteristics. We found
a difference in length of hospital stay following interven-
tion among the groups.
Some authors suggested that if on inspecting the pleural
cavity and trial of thoracoscopic decortication, the
surgeon deemed VATS to be inappropriate (thick peel
preventing lung expansion), the procedure was converted
into a minithoracotomy. This was deemed to be a failure
of VATS [25]. There are no therapeutic or recovery
advantages between VATS and fibrinolysis for the
treatment of empyema; however, VATS resulted in
significantly higher cost. Fibrinolysis should be used as
initial therapy in children with empyema even though
there is less risk of clinical worsening [26].
Early decortication had beneficial effects on pulmonary
perfusion [27]. Fibrinolytic use should be considered in
potential decortication candidates in an effort to avoid
surgery with attendant morbidity [28]. However, surgical
morbidity is low and the mortality rate is very rare. In
contrast, surgery resulted in a low mean empyema and
complete resolution in 100% of patients. In contrast to
studies that favor intrapleural fibrinolytic therapy, in an
experimental animal model, streptokinase and urokinase
were not found to be effective for liquefaction of thick
pleural exudates [29].
Chest tube drainage is a safe, effective primary treatment
of postpneumonic pediatric empyema, especially in
exudative and purulent stages. In cases where chest tube
drainage is insufficient, thoracotomy with decortication
can be used successfully, with low morbidity and
mortality rates [30].
The presence of a thick rind and trapped lungs is an
indication for surgery and decortications [3,31–33]. The
inability to evacuate fibrinous debris through chest
tube is also an indication for decortication. Decortication
should be performed as soon as possible if drainage is not
effective. It may be used as an initial treatment instead of
wasting time by performing thoracotomy. When the
patient’s status is suitable for surgery, we choose this
approach because of the decrease in mortality and
morbidity, reduction of hospital stay, and discharge of
the patient with uneventful recovery.
Conclusion
Fibrinolytic therapy is not an alternative to surgery,
especially in loculated empyemas in children. However, it
should be tried in all cases of fibrinopurulent phase
empyema not responding to closed chest tube drainage.
This treatment increases the success of less invasive
treatment. We prefer open thoracotomy or VATS for
complete lung decortication, in fibrinopurulent cases,
following the escalation process.
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